Using PSMA imaging for prognostication in localized and advanced prostate cancer

Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  Google Scholar 

Mottet, N. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. EAU https://uroweb.org/guidelines/prostate-cancer (2020).

Wallitt, K. L. et al. Clinical PET imaging in prostate cancer. RadioGraphics 37, 1512–1536 (2017).

Article  Google Scholar 

Jadvar, H. Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET. Nat. Rev. Urol. 6, 317–323 (2009).

Article  Google Scholar 

Jadvar, H. Is there use for FDG-PET in prostate cancer? Semin. Nucl. Med. 46, 502–506 (2016).

Article  Google Scholar 

Horoszewicz, J. S. et al. The LNCaP cell line — a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res. 37, 115–132 (1980).

Google Scholar 

Horoszewicz, J. S., Kawinski, E. & Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 7, 927–935 (1987).

Google Scholar 

Wynant, G. E. et al. Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate 18, 229–241 (1991).

Article  Google Scholar 

Robinson, M. B., Blakely, R. D., Couto, R. & Coyle, J. T. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J. Biol. Chem. 262, 14498–14506 (1987).

Article  Google Scholar 

Kozikowski, A. P. et al. Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase). J. Med. Chem. 44, 298–301 (2001).

Article  Google Scholar 

Maurer, T., Eiber, M., Schwaiger, M. & Gschwend, J. E. Current use of PSMA-PET in prostate cancer management. Nat. Rev. Urol. 13, 226–235 (2016).

Article  Google Scholar 

Lawhn-Heath, C. et al. Prostate-specific membrane antigen PET in prostate cancer. Radiology 299, 248–260 (2021).

Article  Google Scholar 

Siva, S. et al. Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer. Nat. Rev. Urol. 17, 107–118 (2020).

Article  Google Scholar 

van Leeuwen, F. W. B. et al. Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer. Nat. Rev. Urol. 16, 159–171 (2019).

Article  Google Scholar 

Wright, G. L. Jr, Haley, C., Beckett, M. L. & Schellhammer, P. F. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol. Oncol. 1, 18–28 (1995).

Article  Google Scholar 

O’Keefe, D. S. et al. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim. Biophys. Acta 1443, 113–127 (1998).

Article  Google Scholar 

DeMarzo, A. M., Nelson, W. G., Isaacs, W. B. & Epstein, J. I. Pathological and molecular aspects of prostate cancer. Lancet 361, 955–964 (2003).

Article  Google Scholar 

Kinoshita, Y. et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J. Surg. 30, 628–636 (2006).

Article  Google Scholar 

Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D. & Cordon-Cardo, C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 3, 81–85 (1997).

Google Scholar 

Ferreira, G., Iravani, A., Hofman, M. S. & Hicks, R. J. Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution. Cancer Imaging 19, 23 (2019).

Article  Google Scholar 

Israeli, R. S., Powell, C. T., Fair, W. R. & Heston, W. D. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53, 227–230 (1993).

Google Scholar 

Barinka, C. et al. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA). Protein Eng. Des. Sel. 29, 105–115 (2016).

Article  Google Scholar 

Pinto, J. T. et al. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res. 2, 1445–1451 (1996).

Google Scholar 

Paschalis, A. et al. Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer. Eur. Urol. 76, 469–478 (2019).

Article  Google Scholar 

Bostwick, D. G., Pacelli, A., Blute, M., Roche, P. & Murphy, G. P. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 82, 2256–2261 (1998).

Article  Google Scholar 

Mannweiler, S. et al. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol. Oncol. Res. 15, 167–172 (2009).

Article  Google Scholar 

Kaittanis, C. et al. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J. Exp. Med. 215, 159–175 (2018).

Article  Google Scholar 

Caromile, L. A. & Shapiro, L. H. PSMA redirects MAPK to PI3K-AKT signaling to promote prostate cancer progression. Mol. Cell. Oncol. 4, e1321168 (2017).

Article  Google Scholar 

Shorning, B. Y., Dass, M. S., Smalley, M. J. & Pearson, H. B. The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci. 21, 4507 (2020).

Article  Google Scholar 

Xu, L. et al. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis. Oncol. Rep. 30, 1920–1928 (2013).

Article  Google Scholar 

Wu, J. et al. A novel fully human antibody targeting extracellular domain of PSMA inhibits tumor growth in prostate cancer. Mol. Cancer Ther. 18, 1289–1301 (2019).

Article  Google Scholar 

Su, Y. et al. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth. Cancer Lett. 338, 282–291 (2013).

Article  Google Scholar 

Kuroda, K. & Liu, H. The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor. Int. J. Oncol. 54, 1357–1366 (2019).

Google Scholar 

Weidle, U. H., Epp, A., Birzele, F. & Brinkmann, U. The functional role of prostate cancer metastasis-related Micro-RNAs. Cancer Genomics Proteom. 16, 1–19 (2019).

Article  Google Scholar 

Vummidi Giridhar, P., Williams, K., VonHandorf, A. P., Deford, P. L. & Kasper, S. Constant degradation of the androgen receptor by MDM2 conserves prostate cancer stem cell integrity. Cancer Res. 79, 1124–1137 (2019).

Article  Google Scholar 

Zhou, Y., Bolton, E. C. & Jones, J. O. Androgens and androgen receptor signaling in prostate tumorigenesis. J. Mol. Endocrinol. 54, R15–R29 (2015).

Article  Google Scholar 

Shore, N. D., Abrahamsson, P. A., Anderson, J., Crawford, E. D. & Lange, P. New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists. Prostate Cancer Prostatic Dis. 16, 7–15 (2013).

Article  Google Scholar 

Bakht, M. K. et al. Influence of androgen deprivation therapy on the uptake of PSMA-targeted agents: emerging opportunities and challenges. Nucl. Med. Mol. Imaging 51, 202–211 (2017).

Article  Google Scholar 

Vaz, S. et al. Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients. Eur. J. Nucl. Med. Mol. Imaging 47, 9–15 (2020).

Article  Google Scholar 

Roy, J. et al. Monitoring PSMA responses to ADT in prostate cancer patient-derived xenograft mouse models using [18F]DCFPyL PET imaging. Mol. Imaging Biol. 23, 745–755 (2021).

Article  Google Scholar 

Hope, T. A. et al. 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience. J. Nucl. Med. 58, 81–84 (2017).

Article  Google Scholar 

Mei, R. et al. Androgen deprivation therapy and its modulation of PSMA expression in prostate cancer: mini review and case series of patients studied with sequential [68Ga]-Ga-PSMA-11 PET/CT. Clin. Transl. Imaging 9, 215–220 (2021).

Article  Google Scholar 

Leitsmann, C. et al. Enhancing PSMA-uptake with androgen deprivation therapy — a new way to detect prostate cancer metastases? Int. Braz. J. Urol. 45, 459–467 (2019).

Article  Google Scholar 

Ettala, O. et al. Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 47, 665–673 (2020).

Article  Google Scholar 

Liu, T., Wu, L. Y., Fulton, M. D., Johnson, J. M. & Berkman, C. E. Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells. Int. J. Oncol. 41, 2087–2092 (2012).

Article  Google Scholar 

Afshar-Oromieh, A. et al. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 45, 2045–2054 (2018).

Article  Google Scholar 

Hoberück, S. et al. [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study. EJNMMI Res. 10, 135 (2020).

Article  Google Scholar 

Wright, G. L. Jr et al. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 48, 326–334 (1996).

Article  Google Scholar 

Chen, M. et al. Can 68Ga-PSMA-11 positron emission tomography/computerized tomography predict pathological response of primary prostate cancer to neoadjuvant androgen deprivation therapy? A pilot study. J. Urol. 205, 1082–1089 (2021).

Article  Google Scholar 

Murga, J. D. et al. Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer. Prostate 75, 242–254 (2015).

Article  Google Scholar 

Evans, M. J. et al. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen. Proc. Natl Acad. Sci. USA 108, 9578–9582 (2011).

Article  Google Scholar 

Emmett, L. et al. Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade. J. Nucl. Med. 60, 950–954 (2019).

Article  Google Scholar 

Minner, S. et al. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. Prostate 71, 281–288 (2011).

Article 

留言 (0)

沒有登入
gif